3 Results for "

group I PAKs

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "group I PAKs" in MCE Product Catalog:

11
11 Cited Publications
Cat. No.: HY-15542A
CAS No.: 1286739-19-2
Purity:  99.36%
Target:  

PAK

Research Areas:  

Cancer

FRAX597 is a potent group I p21-activated Kinases (PAKs) inhibitor with IC50 of 8, 13 and 19 nM for PAK1, 2 and 3.
loading...
    loading...
Cat. No.: HY-174247
Research Areas:  

Cancer

CPS-021 is a selective PAK4 PROTAC degrader with a DC50 of 50 nM. CPS-021 degrades PAK4 via the ubiquitin-proteasome system. CPS-021 inhibits the migration and invasion of tumor cells, suppresses TGFβ-induced epithelial-mesenchymal transition (EMT) in tumor cells, and can be used in studies related to lung cancer metastasis .
loading...
    loading...
Cat. No.: HY-184447
CAS No.: 3091508-49-2
Target:  

PAK

Research Areas:  

Others

RN193 is a type II kinase inhibitor with a human PAK1 IC50 of 4.28 μM. RN193 functionally inhibits kinase activity of PAK1, PAK2, and PAK3, and engages with their kinase domains in live cells. RN193 induces thermal shifts in CLK1, GSK3B, ULK1, MELK, MAPK13, BRAF, and STK10, indicating binding and stabilization of these proteins. RN193 induces formation of PAK3:PAK2 heterodimers and displaces PAK2 homodimers in live cells. RN193 acts as a tool compound for studying group I PAK conformational states .
loading...
    loading...